Egg R - Search Results

1

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.

Gneiss C, Reindl M, Lutterotti A, Ehling R, Egg R, Khalil M, Berger T, Deisenhammer F. Gneiss C, et al. Among authors: egg r. Mult Scler. 2004 Oct;10(5):507-10. doi: 10.1191/1352458504ms1074oa. Mult Scler. 2004. PMID: 15471365

2

Epitope specificity of neutralizing antibodies against IFN-beta.

Gneiss C, Reindl M, Berger T, Lutterotti A, Ehling R, Egg R, Deisenhammer F. Gneiss C, et al. Among authors: egg r. J Interferon Cytokine Res. 2004 May;24(5):283-90. doi: 10.1089/107999004323065066. J Interferon Cytokine Res. 2004. PMID: 15153311

3

Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M. Lutterotti A, et al. Among authors: egg r. J Neuroimmunol. 2006 Dec;181(1-2):145-9. doi: 10.1016/j.jneuroim.2006.09.002. Epub 2006 Oct 13. J Neuroimmunol. 2006. PMID: 17046070

4

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.

Egg R, Reindl M, Deisenhammer F, Linington C, Berger T. Egg R, et al. Mult Scler. 2001 Oct;7(5):285-9. doi: 10.1177/135245850100700503. Mult Scler. 2001. PMID: 11724443

5

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta.

Kob M, Harvey J, Schautzer F, Kascha S, Bibl D, Egg R, Reindl M, Berger T, Deisenhammer F. Kob M, et al. Among authors: egg r. Mult Scler. 2003 Feb;9(1):32-5. doi: 10.1191/1352458503ms889oa. Mult Scler. 2003. PMID: 12617265

6

Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.

Gneiss C, Tripp P, Ehling R, Khalil M, Lutterotti A, Egg R, Mayringer I, Künz B, Berger T, Reindl M, Deisenhammer F. Gneiss C, et al. Among authors: egg r. J Neuroimmunol. 2006 May;174(1-2):174-9. doi: 10.1016/j.jneuroim.2006.01.017. Epub 2006 Mar 23. J Neuroimmunol. 2006. PMID: 16556466 Clinical Trial.

7

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.

Gneiss C, Tripp P, Reichartseder F, Egg R, Ehling R, Lutterotti A, Khalil M, Kuenz B, Mayringer I, Reindl M, Berger T, Deisenhammer F. Gneiss C, et al. Among authors: egg r. Mult Scler. 2006 Dec;12(6):731-7. doi: 10.1177/1352458506070941. Mult Scler. 2006. PMID: 17263000

8

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M. Berger T, et al. Among authors: egg r. N Engl J Med. 2003 Jul 10;349(2):139-45. doi: 10.1056/NEJMoa022328. N Engl J Med. 2003. PMID: 12853586 Free article.

9

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T. Reindl M, et al. Among authors: egg r. Brain. 1999 Nov;122 ( Pt 11):2047-56. doi: 10.1093/brain/122.11.2047. Brain. 1999. PMID: 10545390 Clinical Trial.

10

Increased intrathecal production of apolipoprotein D in multiple sclerosis.

Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, Berger T. Reindl M, et al. Among authors: egg r. J Neuroimmunol. 2001 Oct 1;119(2):327-32. doi: 10.1016/s0165-5728(01)00378-2. J Neuroimmunol. 2001. PMID: 11585636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters